Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases ; volume:8 ; number:1 ; day:18 ; month:5 ; year:2018 ; pages:1-11 ; date:12.2018
Scientific reports ; 8, Heft 1 (18.5.2018), 1-11, 12.2018
- Creator
-
Sauzullo, Ilaria
- Contributor
-
Scrivo, Rossana
Sessa, Paola
Mengoni, Fabio
Vullo, Vincenzo
Valesini, Guido
Mastroianni, Claudio Maria
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-26097-x
- URN
-
urn:nbn:de:101:1-2018071717402104043937
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sauzullo, Ilaria
- Scrivo, Rossana
- Sessa, Paola
- Mengoni, Fabio
- Vullo, Vincenzo
- Valesini, Guido
- Mastroianni, Claudio Maria
- SpringerLink (Online service)
Other Objects (12)
Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
Pulmonary thromboembolism in children with rheumatic diseases
Postnatal Care of Woman with Rheumatic Diseases
Second generation of calcium antagonists : with 63 tables
Oculocutaneous manifestations of rheumatic diseases : with 9 tables
Biosensor-based monitoring of TNF antagonists and anti-drug antibodies in inflammatory bowel disease
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
CNS Demyelination with TNF-α Blockers
Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
Pulmonary thromboembolism in children with rheumatic diseases
Postnatal Care of Woman with Rheumatic Diseases
Second generation of calcium antagonists : with 63 tables
Oculocutaneous manifestations of rheumatic diseases : with 9 tables
Biosensor-based monitoring of TNF antagonists and anti-drug antibodies in inflammatory bowel disease
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
CNS Demyelination with TNF-α Blockers
Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
Pulmonary thromboembolism in children with rheumatic diseases
Postnatal Care of Woman with Rheumatic Diseases
Second generation of calcium antagonists : with 63 tables
Oculocutaneous manifestations of rheumatic diseases : with 9 tables
Biosensor-based monitoring of TNF antagonists and anti-drug antibodies in inflammatory bowel disease
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment